{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:19:42Z","timestamp":1790007582904,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bulcan.2025.01.007","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:19:24Z","timestamp":1740485964000},"page":"425-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Constipation induite par les opio\u00efdes\u00a0: \u00e9tat des lieux et modalit\u00e9s de prise en charge"],"prefix":"10.1016","volume":"112","author":[{"given":"Alice","family":"Boil\u00e8ve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Desprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Scott\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heithem","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2025.01.007_bib0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ejp.1291","article-title":"Prescription opioid analgesic use in France: trends and impact on morbidity-mortality","volume":"23","author":"Chenaf","year":"2019","journal-title":"Eur J Pain"},{"issue":"6","key":"10.1016\/j.bulcan.2025.01.007_bib0180","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bulcan.2025.01.007_bib0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11894-017-0560-2","article-title":"Opioid-related constipation in patients with non-cancer pain syndromes: a review of evidence-based therapies and justification for a change in nomenclature","volume":"19","author":"Brenner","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.bulcan.2025.01.007_bib0190","series-title":"\u00c9tat des lieux de la consommation des antalgiques opio\u00efdes et leurs usages probl\u00e9matiques","year":"2019"},{"key":"10.1016\/j.bulcan.2025.01.007_bib0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.sjpain.2015.12.005","article-title":"Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction\u00a0\u2013\u00a0Recommendations of the Nordic Working Group","volume":"11","author":"Drewes","year":"2016","journal-title":"Scand J Pain"},{"issue":"4","key":"10.1016\/j.bulcan.2025.01.007_bib0200","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/2050640616659967","article-title":"Prevalence and clinical features of opioid-induced constipation in the general population: a French study of 15,000\u00a0individuals","volume":"5","author":"Ducrott\u00e9","year":"2017","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.bulcan.2025.01.007_bib0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer","year":"2019","journal-title":"United Eur Gastroenterol J"},{"issue":"1\u20133","key":"10.1016\/j.bulcan.2025.01.007_bib0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2009.03.012","article-title":"Opioid receptors in the gastrointestinal tract","volume":"155","author":"Holzer","year":"2009","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.bulcan.2025.01.007_bib0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2468-1253(18)30008-6","article-title":"Pathophysiology, diagnosis, and management of opioid-induced constipation","volume":"3","author":"Farmer","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.bulcan.2025.01.007_bib0220","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5056\/jnm15175","article-title":"The impact of opioid treatment on regional gastrointestinal transit","volume":"22","author":"Poulsen","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.bulcan.2025.01.007_bib0225","series-title":"Physiology of the gastro-intestinal tract","author":"Johnson","year":"2006"},{"issue":"1","key":"10.1016\/j.bulcan.2025.01.007_bib0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ajgsup.2014.5","article-title":"Molecular physiology of enteric opioid receptors","volume":"2","author":"Galligan","year":"2014","journal-title":"Am J Gastroenterol Suppl"},{"issue":"2","key":"10.1016\/j.bulcan.2025.01.007_bib0235","doi-asserted-by":"crossref","first-page":"e1376","DOI":"10.1111\/nmo.13762","article-title":"European society of neurogastroenterology and motility guidelines on functional constipation in adults","volume":"32","author":"Serra","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"11","key":"10.1016\/j.bulcan.2025.01.007_bib0240","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.mayocp.2019.01.031","article-title":"Chronic constipation","volume":"94","author":"Bharucha","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.bulcan.2025.01.007_bib0245","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1007\/s00520-022-07002-9","article-title":"Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis","volume":"30","author":"Kanbayashi","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2025.01.007_bib0250","doi-asserted-by":"crossref","first-page":"5165682","DOI":"10.1155\/2020\/5165682","article-title":"Prevalence and risk factors for opioid-induced constipation in an older national veteran cohort","volume":"2020","author":"FitzHenry","year":"2020","journal-title":"Pain Res Manag"},{"issue":"4","key":"10.1016\/j.bulcan.2025.01.007_bib0255","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2982.2009.01458.x","article-title":"Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain","volume":"22","author":"Tuteja","year":"2010","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.bulcan.2025.01.007_bib0260","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/annonc\/mdw097","article-title":"Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV \u201creal life\u201d trial on the variability of response to opioids","volume":"27","author":"Corli","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.01.007_bib0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer","year":"2019","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"10.1016\/j.bulcan.2025.01.007_bib0270","doi-asserted-by":"crossref","first-page":"e13762","DOI":"10.1111\/nmo.13762","article-title":"European society of neurogastroenterology and motility guidelines on functional constipation in adults","volume":"32","author":"Serra","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.bulcan.2025.01.007_bib0275","doi-asserted-by":"crossref","first-page":"iv111","DOI":"10.1093\/annonc\/mdy148","article-title":"Diagnosis, assessment and management of constipation in advanced cancer: ESMO clinical practice guidelines","volume":"29","author":"Larkin","year":"2018","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.bulcan.2025.01.007_bib0280","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.051528","article-title":"Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects","volume":"174","author":"Furlan","year":"2006","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.bulcan.2025.01.007_bib0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1572-0241.2005.40885.x","article-title":"Myths and misconceptions about chronic constipation","volume":"100","author":"M\u00fcller-Lissner","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.bulcan.2025.01.007_bib0290","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.14309\/ajg.0000000000000413","article-title":"Is dyssynergic defecation an unrecognized cause of chronic constipation in patients using opioids?","volume":"114","author":"Nojkov","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.01.007_bib0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4637.2008.00495.x","article-title":"The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1)","volume":"10","author":"Bell","year":"2009","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.bulcan.2025.01.007_bib0300","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s40122-021-00271-y","article-title":"Impact and consequences of opioid-induced constipation: a survey of patients","volume":"10","author":"Varrassi","year":"2021","journal-title":"Pain Ther"},{"issue":"10","key":"10.1016\/j.bulcan.2025.01.007_bib0305","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/ajg.2013.169","article-title":"Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis","volume":"108","author":"Ford","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.bulcan.2025.01.007_bib0310","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jpainsymman.2011.12.002","article-title":"Stimulant laxatives and opioid-induced constipation","volume":"43","author":"Twycross","year":"2012","journal-title":"J Pain Symptom Manage"},{"issue":"22","key":"10.1016\/j.bulcan.2025.01.007_bib0315","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.bulcan.2025.01.007_bib0320","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1310246","article-title":"Naloxegol for opioid-induced constipation in patients with noncancer pain","volume":"370","author":"Chey","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bulcan.2025.01.007_bib0325","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2468-1253(17)30105-X","article-title":"Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1\u00a0and COMPOSE-2): two multicentre, phase 3, double-blind, randomized, parallel-group trials","volume":"2","author":"Hale","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"17_suppl","key":"10.1016\/j.bulcan.2025.01.007_bib0330","doi-asserted-by":"crossref","first-page":"LBA12014","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA12014","article-title":"Preventive effect of naldemedine for opioid-induced constipation in patients with cancer starting opioids: a multicenter, double-blinded, randomized, placebo-controlled, phase 3\u00a0trial","volume":"42","author":"Hamano","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.01.007_bib0335","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpain.2008.06.012","article-title":"A randomized controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation","volume":"13","author":"Meissner","year":"2009","journal-title":"Eur J Pain"},{"issue":"10","key":"10.1016\/j.bulcan.2025.01.007_bib0170","first-page":"1837","article-title":"Opioid-induced constipation and bowel dysfunction: a clinical guideline","volume":"18","author":"M\u00fcller-Lissner","year":"2017","journal-title":"Pain Med"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:42:37Z","timestamp":1743727357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455125000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0007455125000669"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.01.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constipation induite par les opio\u00efdes\u00a0: \u00e9tat des lieux et modalit\u00e9s de prise en charge","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}